Research Projects in Dry Eye Syndrome

Editor(s): Brewitt, H. (Hannover)
 

Generation of Two- and Three-Dimensional Lacrimal Gland Constructs

Schrader S.a,b,d · Liu L.c · Kasper K.e · Geerling G.e

Author affiliations

aCells for Sight Transplantation and Research Programme, Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, and bMoorfields Eye Hospital NHS Foundation Trust, London, and cAcademic Unit of Ophthalmology, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; dDepartment of Ophthalmology, University of Lübeck, Lübeck, and eDepartment of Ophthalmology, Julius Maximilian University Würzburg, Würzburg, Germany

Related Articles for ""

Brewitt H (ed): Research Projects in Dry Eye Syndrome. Dev Ophthalmol. Basel, Karger, 2010, vol 45, pp 49–56

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: May 18, 2010
Cover Date: 2010

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-9418-9 (Print)
eISBN: 978-3-8055-9419-6 (Online)

Abstract

Aqueous tear deficiency due to lacrimal gland insufficiency is one of the major causes of dry eye. In severe cases, such as Sjoegren’s syndrome, Stevens-Johnson syndrome or ocular cicatricial pemphigoid, therapy with artificial tears can be insufficient to relieve severe discomfort. Engineering a lacrimal gland construct may offer a suitable alternative transplant with a tear-like secretion. However, the reconstruction of a complex structure such as the lacrimal gland is challenging, and a lacrimal gland substitute must meet several criteria. It has to contain enough functional lacrimal gland cells to produce an adequate amount of tear fluid, and a suitable matrix is needed to deliver the cells to the patient. The growing field of regenerative medicine offers promising new prospects for lacrimal gland reconstruction. This article summarizes our group’s current work in developing models for lacrimal gland reconstruction, and also discusses the perspectives of a tissue-engineered lacrimal gland for future applications.

© 2010 S. Karger AG, Basel




Related Articles:


References

  1. Perry HD: Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care 2008;14:79-87
  2. Selvam S, Thomas PB, Yiu SC: Tissue engineering: current and future approaches to ocular surface reconstruction. Ocul Surf 2006;4:120-136
  3. Hann LE, Tatro JB, Sullivan DA: Morphology and function of lacrimal gland acinar cells in primary culture. Invest Ophthalmol Vis Sci 1989;30:145-158
  4. Bradley ME, Lambert RW, Lambert RW, Lee LM, Mircheff AK: Isolation and subcellular fractionation analysis of acini from rabbit lacrimal glands. Invest Ophthalmol Vis Sci 1992;33:2951-2965
  5. Yoshino K, Tseng SC, Pflugfelder SC: Substrate modulation of morphology, growth, and tear protein production by cultured human lacrimal gland epithelial cells. Exp Cell Res 1995;220:138-151
  6. Selvam S, Thomas PB, Trousdale MD, Stevenson D, Schechter JE, Mircheff AK, Jacob JT, Smith RE, Yiu SC: Tissue-engineered tear secretory system: functional lacrimal gland acinar cells cultured on matrix protein-coated substrata. J Biomed Mater Res B Appl Biomater 2007;80:192-200
  7. Azuara-Blanco A, Pillai CT, Dua HS: Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999;83:399-402
  8. Schrader S, et al: Amniotic membrane as a carrier for lacrimal gland acinar cells. Graefes Arch Clin Exp Ophthalmol 2007;245:1699-1704
  9. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S: Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008;321:699-702
  10. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317
  11. Meller D, Tseng SC: Conjunctival epithelial cell differentiation on amniotic membrane. Invest Ophthalmol Vis Sci 1999;40:878-886
  12. Koizumi N, Inatomi T, Quantock AJ, Fullwood NJ, Dota A, Kinoshita S: Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 2000;19:65-71
  13. Schwab IR: Cultured corneal epithelia for ocular surface disease. Trans Am Ophthalmol Soc 1999;97:891-986
  14. Honavar SG, Bansal AK, Sangwan VS, Rao GN: Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 2000;107:975-979
  15. Lee SH, Tseng SC: Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997;123:303-312
  16. Barabino S, Rolando M, Bentivoglio G, Mingari C, Zanardi S, Bellomo R, Calabria G: Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatrical pemphigoid. Ophthalmology 2003;110:474-480
  17. Ang LP, Tan DT, Cajucom-Uy H, Beuerman RW: Autologous cultivated conjunctival transplantation for pterygium surgery. Am J Ophthalmol 2005;139:611-619
  18. Nakamura T, Inatomi T, Sotozono C, Amemiya T, Kanamura N, Kinoshita S: Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br J Ophthalmol 2004;88:1280-1284
  19. Lewis ML, Moriarity DM, Campbell PS: Use of microgravity bioreactors for development of an in vitro rat salivary gland cell culture model. J Cell Biochem 1993;51:265-273
  20. Becker JL, Prewett TL, Spaulding GF, Goodwin TJ: Three-dimensional growth and differentiation of ovarian tumor cell line in high aspect rotating-wall vessel: morphologic and embryologic considerations. J Cell Biochem 1993;51:283-289
  21. Goodwin TJ, Jessup JM, Wolf DA: Morphologic differentiation of colon carcinoma cell lines HT-29 and HT-29KM in rotating-wall vessels. In Vitro Cell Dev Biol 1992;28A:47-60
  22. Hatfill SJ, Margolis LB, Duray PH: In vitro maintenance of normal and pathological human salivary gland tissue in a NASA-designed rotating wall vessel bioreactor. Cell Vision 1996;3:5
  23. Schrader S, Kremling C, Klinger M, Laqua H, Geerling G: Cultivation of lacrimal gland acinar cells in a microgravity environment. Br J Ophthalmol 2009;93:1121-1125
  24. Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R: De Luca M: Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997;349:990-993
  25. Schrader S, Notara M, Beaconsfield M, Tuft S, Geerling G, Daniels JT: Conjunctival epithelial cells maintain stem cell properties after long-term culture and cryopreservation. Regen Med 2009;4:677-687
  26. Kishi T, Takao T, Fujita K, Taniguchi H: Clonal proliferation of multipotent stem/progenitor cells in the neonatal and adult salivary glands. Biochem Biophys Res Commun 2006;340:544-552
  27. Holland AM, Gonez LJ, Harrison LC: Progenitor cells in the adult pancreas. Diabetes Metab Res Rev 2004;20:13-27
  28. Zhang YQ, Kritzik M, Sarvetnick N: Identification and expansion of pancreatic stem/progenitor cells. J Cell Mol Med 2005;9:331-344
  29. Zoukhri D, Fix A, Alroy J, Kublin CL: Mechanisms of murine lacrimal gland repair after experimentally induced inflammation. Invest Ophthalmol Vis Sci 2008;49:4399-4406
  30. Geerling G, Sieg P, Bastian GO, Laqua H: Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca. Ophthalmology 1998;105:327-335
  31. Revoltella RP, Papini S, Rosellini A, Michelini M: Epithelial stem cells of the eye surface. Cell Prolif 2007;40:445-461
  32. Meller D, Dabul V, Tseng SC: Expansion of conjunctival epithelial progenitor cells on amniotic membrane. Exp Eye Res 2002;74:537-545
  33. Meller D, Pires RT, Tseng SC: Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br J Ophthalmol 2002;86:463-471
  34. Tsai RJ, Li LM, Chen JK: Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000;343:86-93
  35. Matsumoto T, Mooney DJ: Cell instructive polymers. Adv Biochem Eng Biotechnol 2006;102:113-137

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: May 18, 2010
Cover Date: 2010

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-9418-9 (Print)
eISBN: 978-3-8055-9419-6 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP